PATENT CLAIM ANALYSIS

Application Number: 16160724
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["514", "002900"]

Abstract:
In one aspect, the invention relates to substituted urea depsipeptide analogs, derivatives thereof, and related compounds, which are useful as activators the ClpP endopeptidease; synthesis methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating infectious disease using the compounds and compositions. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

Claim (Index 17):
The method of  claim 14 , wherein the bacterial infection is selected from urinary tract infection, skin infection, intestinal infection, lung infection, ocular infection, otitis, sinusitis, pharyngitis, osteo-articular infection, genital infection, dental infection, oral infection, septicemia, nocosomial infection, bacterial meningitis, gastroenteritis, gastritis, diarrhea, ulcer, endocarditis, sexually transmitted disease, tetanus, diphtheria, leprosy, cholera, listeriosis, tuberculosis, salmonellosis, dysentery, and soft tissue.

Metadata:
- Claim Count in Document: 46.0
- Percentile: 97.0
- Lexical Diversity: 1.51852
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15554707', '14914449', '16329168', '15863673', '14380659']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.875550020936412
- 35 USC 102 Novelty (BERT): 0.67638140404393
- Combined Prediction Score: 0.8556331592471638
- Mean Citation Score: 654.553988
- Max Citation Score: 800.62445
- Similarity Product: 642.4363237293422

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test